Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCity Lon Inv Regulatory News (CLIG)

Share Price Information for City Lon Inv (CLIG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 360.00
Bid: 351.00
Ask: 366.00
Change: 2.00 (0.56%)
Spread: 15.00 (4.274%)
Open: 358.00
High: 360.00
Low: 358.00
Prev. Close: 358.00
CLIG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update - 1st Quarter FuM

8 Oct 2018 07:00

RNS Number : 2045D
City of London Investment Group PLC
08 October 2018
 

8th October 2018

 

CITY OF LONDON INVESTMENT GROUP PLC

("City of London", "the Company" or "the Group")

 

 

Trading Update - 1st Quarter Funds under Management (FuM)

 

City of London (LSE: CLIG), a leading specialist asset management group offering a range of institutional products investing in closed-end funds, announces that as at 30th September 2018, FuM were US$5.0 billion (£3.8 billion). This compares with US$5.1 billion (£3.9 billion) at the Company's year-end on 30th June 2018. A breakdown by strategy follows:

 

 

FuM ($mn)

Strategy Index

Sep-18

Jun-18

%

Net

%

(estimate)

inc/dec

Flows

inc/dec

EM

4,016

4,207

-5%

(95)

MSCI EM

-1%

DEV

577

481

20%

98

MSCI ACWI

4%

Frontier

215

245

-12%

(21)

MSCI Frontier

-2%

Opportunistic Value

200

174

15%

26

ACWI/Barclays Global Agg

2%

5,008

5,107

8

 

Note: Opportunistic Value includes the new Municipal Bond strategy.

 

IM Performance

 

IM performance was slightly behind benchmark over the quarter. Specifically, in the Emerging Market and Frontier strategies underlying NAV performance was weak (that is, the underlying closed-end fund managers underperformed their relevant benchmark indices). In the Developed strategy relative returns were impacted by widening discounts.

 

Flows were neutral over the quarter. The EM, Frontier and Opportunistic value strategies saw rebalancing outflows which were offset by continued strong flows into the Developed strategy and the funding of a new Municipal bond mandate.

 

Operations

 

The Group's income currently accrues at a weighted average rate of approximately 77 basis points of FuM, net of third party commissions. "Fixed" costs are c. £1.1 million per month, and accordingly the current run-rate for operating profit, before profit-share of 30% and an estimated EIP charge of 4%, is approximately £1.4 million per month based upon current FuM and a US$/£ exchange rate of US$1.3 to £1 as at 30th September 2018.

 

The Group estimates that the post-tax profit for the first three months of the year will be approximately £2.2 million (2017: £2.5 million).

 

Dividends

 

The final dividend of 18 pence per share, subject to approval at the AGM on 22nd October 2018, will be paid on 30th October 2018, bringing the total dividend for the financial year 2017-18 to 27 pence (2016-17: 25 pence).

 

 

 

For further information please visit www.citlon.co.uk or contact:

Barry Olliff (CEO)

City of London Investment Group PLC

Tel: 001 215 313 3774

 

Martin Green

Zeus Capital Limited

Financial Adviser & Broker

Tel: +44 (0)20 3829 5000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTUBAKRWUARRAA
Date   Source Headline
20th Feb 20094:09 pmRNSDividend reinvestment plan
11th Feb 20094:55 pmRNSHolding(s) in Company
9th Feb 200911:03 amRNSDirector/PDMR Shareholding
4th Feb 20093:16 pmRNSDirector/PDMR Shareholding
4th Feb 200912:04 pmRNSHolding(s) in Company
30th Jan 20099:32 amRNSTotal Voting Rights
28th Jan 20094:02 pmRNSDirector/PDMR Shareholding & TVR
28th Jan 20097:00 amRNSHalf Yearly Report
21st Jan 200912:16 pmRNSHolding(s) in Company
13th Jan 20099:00 amRNSBlock Admission & TVR
8th Dec 20087:34 amRNSFunds under Management - Replacement
8th Dec 20087:00 amRNSFunds Under Management
27th Nov 20084:31 pmRNSDirector/PDMR Shareholding
7th Nov 20089:09 amRNSDirector/PDMR Shareholding
3rd Nov 20087:00 amRNSChange of Registered Office
28th Oct 20087:00 amRNSResult of AGM
27th Oct 20087:00 amRNSAGM Trading Update
8th Oct 200810:01 amRNSChange of Adviser Name
30th Sep 200812:18 pmRNSDirector/PDMR Shareholding
30th Sep 200810:04 amRNSDirector/PDMR Shareholding
22nd Sep 20081:04 pmRNSNotifiable Interest
15th Sep 20087:00 amRNSFinal Results
14th Jul 20086:03 pmRNSDirector/PDMR Shareholding
10th Jun 20087:00 amRNSDirector/PDMR Shareholding
9th Jun 20087:00 amRNSTrading Update
19th May 20082:34 pmRNSDirectorate Change
28th Apr 20083:50 pmRNSNotifiable Interest
23rd Apr 20087:00 amRNSNotifiable Interest
18th Apr 20085:00 pmRNSNotifiable Interest
18th Apr 20083:36 pmRNSDirector/PDMR Shareholding
31st Mar 20089:56 amRNSTotal Voting Rights
27th Mar 20087:01 amRNSDirector/PDMR Shareholding
26th Mar 20082:24 pmRNSAppointment of Joint Broker
17th Mar 200810:51 amRNSNotifiable Interest
10th Mar 20087:00 amRNSFunds Under Management
29th Feb 20085:01 pmRNSNotifiable Interest
29th Feb 20085:00 pmRNSNotifiable Interest
29th Feb 20087:01 amRNSBuyback & Directors' Dealing
7th Feb 20089:57 amRNSDirector/PDMR Shareholding
6th Feb 20087:01 amRNSDirector/PDMR Shareholding
29th Jan 20087:00 amRNSInterim Results
18th Jan 200811:47 amRNSNotice of Results Correction
18th Jan 20089:07 amRNSNotice of Results
10th Dec 20077:00 amRNSFunds Under Management
30th Nov 20077:01 amRNSDirector/PDMR Shareholding
29th Oct 200712:44 pmRNSResult of AGM
29th Oct 20077:00 amRNSTrading Update
24th Sep 20073:38 pmRNSDirector/PDMR Shareholding
19th Sep 20074:32 pmRNSDirector/PDMR Shareholding
17th Sep 20077:01 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.